Login / Signup

Content validity of preference-based measures for economic evaluation in chronic obstructive pulmonary disease.

Ava MehdipourSachi O'HoskiMarla K BeauchampJoshua WaldAyse Kuspinar
Published in: Health and quality of life outcomes (2021)
The majority of GPBMs covered approximately half of the areas reported as being important to individuals with COPD. When areas relevant to COPD are not captured, HRQoL scores generated by these measures may inaccurately reflect patients' values and affect cost-effectiveness decisions.
Keyphrases
  • chronic obstructive pulmonary disease
  • end stage renal disease
  • lung function
  • ejection fraction
  • chronic kidney disease
  • patient reported outcomes
  • cystic fibrosis
  • patient reported
  • air pollution